Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth. The findings were published in a recent Journal of Vision article, Owls see in stereo much like humans do.
Nicolas G. Bazan, MD, PhD, FARVO, of Louisiana State University (LSU) Health Sciences Center in New Orleans, is the new chair of the ARVO Foundation for Eye Research (AFER). He succeeds Gary W. Abrams, MD, FARVO, of Wayne State University/Kresge Eye Institute.
Members of the Association for Research in Vision and Ophthalmology (ARVO) have elected David Beebe, PhD, FARVO, the new editor-in-chief of the ARVO journal Investigative Ophthalmology & Visual Science (IOVS).
Members of the Association for Research in Vision and Ophthalmology (ARVO) have elected Denis Levi, OD, PhD, the editor-in-chief of its Journal of Vision (JOV).
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended in May.
The Association for Research in Vision and Ophthalmology (ARVO) is pleased to announce its 2011 ARVO Award recipients. These award recipients will be acknowledged at the ARVO 2011 Annual Meeting, May 1 – 5, in Fort Lauderdale, Fla.
The Association for Research in Vision and Ophthalmology (ARVO) is pleased to announce this year’s class of distinguished fellows. The title of Fellow of ARVO (FARVO) recognizes members for their accomplishments,
The first global consensus report on meibomian gland dysfunction — a major cause of lid disease and evaporative dry eye — has been published in a special issue of the Investigative Ophthalmology & Visual Science (IOVS) journal. The report is the result of findings from a two-year-long workshop composed of more than 50 leading clinical and basic research experts from around the world.
Karl Deisseroth, MD, PhD, has been named the first recipient of the Ludwig von Sallman Clinician-scientist Award, presented by the ARVO Foundation for Eye Research (AFER) to a clinician-scientist under age 40. Deisseroth, associate professor of Bioengineering and Psychiatry at Stanford University, is being recognized for his ground breaking work in developing and using optogenetic approaches to study neuronal function.
It is no surprise to scientists that the largest social network on the web is called Facebook. Identifying people by their face is fundamental to our social interactions, one of the primary reasons vision researchers are trying to find out how our brain processes facial identity. In a study recently published in the Journal of Vision, scientists used an original approach — a method that “shakes” the brain gently and repeatedly by making an image appear and disappear at a constant rate — to evaluate its sensitivity to perceiving facial identity. The technique is called steady-state visual evoked potential (SSVEP).
Springtime may be just what the doctor orders for individuals suffering from dry eye condition, a disorder resulting from insufficient tear production or altered tear film composition. According to a study published in Investigative Ophthalmology & Visual Science, a temperature less than 30 degrees Celsius on the eye and eyelid could be the cause for the onset or worsening of the disorder.
The National Eye Institute (NEI) and Food and Drug Administration (FDA) are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity. These assessments may provide valuable information that will corroborate standard clinical test outcomes.
Leading researchers and commercial experts will describe unmet needs as well as promising treatments for retinal disease and ocular surface disorders at an April 29 seminar in Fort Lauderdale, Fla., that aims to help investors better understand the scientific and commercial environment of ophthalmic research.
The vision community is discussing with the Food and Drug Administration (FDA) how vision-related patient-reported outcomes (PROs) might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, policymakers and representatives from industry and vision associations — attended a one-day symposium sponsored by the National Institutes of Health’s National Eye Institute (NEI) and the FDA on October 13, 2009.
A new study suggests that older adults who wear multifocal contact lenses to correct problems with near vision, a very common condition that increases with age, may have greater difficulty driving at night than their counterparts who wear glasses. Age-related problems with near vision, medically termed presbyopia, usually occurs after the age of 40 and results in the inability to focus on objects up close.
The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a Glaucoma Endpoints conference on September 24, 2010, to develop definitions and standards for describing structural changes in the glaucomatous optic nerve and functional changes in vision, as criteria for approval of new glaucoma therapeutics in clinical trials. The one-day meeting will take place at the Natcher Center, National Institutes of Health in Bethesda, Md.
Bird observatories all over the world may benefit from a newly designed high-resolution imaging system used to study the retinal structure of live birds of prey. In a recently published Investigative Ophthalmology & Visual Science article, researchers reveal unprecedented three-dimensional information about the retina of four species of raptors — two hawks and two owls — using the non-invasive, powerful imaging tool.
New research finds that the further drivers can look ahead, generally in left-hand curves, wide curves and when leaving a curve, the less they have to look at the tangent point. Research team reports ultimate goal of the findings is to build a device into cars that warns drivers if they is in danger of unintentionally departing from the lane.
Scientists have just come several steps closer to understanding change blindness — the well studied failure of humans to detect seemingly obvious changes to scenes around them — with new research that used a computer-based model to predict what types of changes people are more likely to notice.
More than 16 people are killed and more than 1,300 people are injured each day in crashes involving a distracted driver, a phenomenon that could be reduced with the right application of motion information and appropriate eye movements. Two studies conducted at Vanderbilt University and published in the Journal of Vision found that these factors can be beneficial to teaching people how to track objects without getting distracted or confused.
May protect the lens against damage that could lead to the formation of cataracts,
Study subjects with less physical activity and more television viewing time had wider retinal vascular caliber, associated with heart disease, higher blood pressure and other conditions.
Researchers test contact lens that fully corrects central vision but reduces relative peripheral farsightedness
Study finds people without migraines can filter out more visual noise.
New guidelines that outline best practices for measuring the economic burden of visual impairment will make it easier for the policy, science and medical communities to draw conclusions and compare results across studies.
A new study reported in Investigative Ophthalmology & Visual Science found that UV-blocking contact lenses can reduce or eliminate the effects of the sun’s harmful UV radiation.
To test three theories that might explain an outfielder’s ability to catch a fly ball, researcher Philip Fink, PhD, from Massey University in New Zealand and Patrick Foo, PhD, from the University of North Carolina at Ashville programmed Brown University’s virtual reality lab, the VENLab, to produce realistic balls and simulate catches. The team then lobbed virtual fly balls to a dozen experienced ball players.
The Association for Research in Vision and Ophthalmology is honored to announce this year’s class of distinguished Fellows. The title of ARVO Fellow recognizes members for their accomplishments, leadership and contributions to the Association.
“Why is it that men can be bastards and women must wear pearls and smile?” wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision, may lie in our interpretation of facial expressions.
The ARVO Foundation for Eye Research (AFER) and Pfizer Ophthalmics are pleased to announce a series of awards named in honor of Carl B. Camras, MD. Up to three awards of $10,000 each will be presented annually for a period of 10 years to early career researchers.
Although we assume we can see everything in our field of vision, the brain actually picks and chooses the stimuli that come into our consciousness. A new study in the Association for Research in Vision and Ophthalmology’s Journal of Vision reveals that our brains can be trained to consciously see stimuli that would normally be invisible.
At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn’t necessarily involve eye surgery.
Researchers have long known of the brain’s ability to learn based on visual motion input, and a recent study has uncovered more insight into where the learning occurs.
Scientists have ample evidence that individuals use a variety of cues to identify their own kin. People can also detect resemblances in families other than their own. A new study shows that their success in doing so is the same, whether or not those families are the same race as themselves.
Eighty-four percent of all causes of blindness are either preventable or treatable, study finds.
New drug-releasing contact lenses ensure glaucoma patients and others get correct and consistent dosages of medication. This could be a significant improvement on the traditional eyedrops that ophthalmologists prescribe for these patients, from which the eye absorbs as little as 1% of the dose.
Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either "nature" or "nurture". Researchers think these factors, when used in the proper model, can be strong predictors of the disease.
Nicholas Delamere, PhD (University of Arizona) is the new president of the Association for Research in Vision and Ophthalmology, taking over from Todd Margolis, MD, PhD (University of California-San Francisco), whose one-year term ended in May.
The Association for Research in Vision and Ophthalmology (ARVO) is pleased to announce its 2009 award recipients. Five individuals will be recognized at the ARVO Annual Meeting, May 3-7 in Fort Lauderdale, Fla.
The Association for Research in Vision and Ophthalmology is honored to announce this year's inaugural class of distinguished Fellows. The title of ARVO Fellow recognizes members for their accomplishments, leadership and contributions to the Association. The two levels of Fellows, Gold and Silver, are determined by a rigorous point system.
Four researchers under age 45 have been named as recipients of the 2009 ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA), worth a total of $70,000 for the researchers and their laboratories. The IORA "” made possible by a generous grant from Merck & Co. to the ARVO Foundation for Eye Research "” encourages scientists to undertake investigative work in critical areas of ophthalmology that could lead to meaningful improvements to patients' lives.
Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration. The challenge to find a solution brought together a panel of 39 scientists for the Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
"Who deserves to see?" Hugh R. Taylor keynotes a major forum of more than 10,000 eye researchers. In addition to thousands of poster and paper sessions, lectures address eye health care across racial, ethnic, gender, age, geographic and socioeconomic groups.
Ever get a little motion sick from an illusion graphic designed to look like it's moving? A new study suggests that these illusions do more than trick the eye; they may also convince the brain that the graphic is actually moving.
With 30 million drivers in the US aged 65 and over, we count on older Americans to recognize when they can no longer drive safely and decide that it's time to stay off the road. A new study finds that a decrease in vision function is a key factor in bringing about this decision.
The ARVO Foundation for Eye Research (AFER) and Merck & Co., Inc. are pleased to announce a series of awards that honor young scientists throughout the world for their innovative contributions to ophthalmology research. Each award cycle is worth a total of $70,000 in grants.
A study recently published in ARVO's online Journal of Vision may inform the next generation of in-car driving assistance systems. New research finds that when drivers fix their gaze on specific targets placed strategically along a curve, their steering is smoother and more stable than it is in normal conditions.
Researchers are making great strides in using imaging techniques to explore the human brain and visual system. On August 1, the Journal of Vision (JOV) opened a special issue dedicated to neuroimaging in vision science. For the first time, JOV gives vision researchers of varied methodological persuasions access to a collection of high-quality imaging studies of visual processing.
For the first time, a study combines measurements of abnormalities in the eye with models for assessing how well an individual can see, meaning it may be possible to program a machine to automatically produce prescriptions for corrective lenses.
Todd Margolis, MD, PhD (University of California-San Francisco) is the new president of the Association for Research in Vision and Ophthalmology, taking over from Martine Jager, MD, PhD (Leiden University, The Netherlands), whose one-year term ended in April. Donald Hood, PhD (Columbia University) and Barry Winkler, PhD (Oakland University) will serve as vice presidents. Nicholas Delamere, PhD (University of Arizona) has been named president-elect; he will serve the 2009-2010 term. Paul Sternberg, MD (Vanderbilt Eye Institute) is vice-president elect for that term.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right